{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:18:54Z","timestamp":1758845934466,"version":"3.44.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To evaluate clinical and CT imaging features on portal venous-phase for predicting microvascular invasion (MVI) in patients with pancreatic neuroendocrine tumors (PNETs) and compare survival outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>In this retrospective study, 160 patients (training group) and 28 (validation group) who underwent surgical resection for PNETs were included. Demographic data and CT features were collected. The independent predictive factors for predicting MVI were confirmed through univariate and multivariate logistic regression analyses. The predictive performance was assessed by employing the receiver operating characteristic curve for predicting MVI. An R\/shiny app based on logistic regression was developed. A Kaplan-Meier survival analysis with a log-rank test was conducted.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In the training group, invasion of surrounding tissues (odds ratio [OR]: 4.12), absolute enhancement (OR: 0.84), and relative enhancement ratio (OR: 16.1) were identified as independent predictors for predicting MVI in PNET patients, with an area under the curve of 0.819 and 0.891 in the training and validation groups, respectively. We have successfully developed a user-friendly web-based R\/shiny app for real-time prediction of MVI in patients with PNETs. The median overall survival for patients with MVI was 12 months, compared to 37.5 months for those without MVI (log-rank <jats:italic>p<\/jats:italic>\u2009=\u20090.034).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Imaging features from portal venous-phase CT images can be used to accurately predict the presence of MVI in patients with PNETs. Patients with MVI are associated with worse survival compared to those without MVI. The web-based R\/shiny app for predicting MVI provides real-time data-driven estimates of predictive value to facilitate informed decision-making.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Critical relevance statement<\/jats:title>\n            <jats:p>Imaging features can accurately predict MVI in patients with PNETs, and the web-based R\/shiny app provides real-time, data-driven estimates to enhance decision-making, thereby streamlining clinical practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>The presence of microvascular invasion (MVI) in patients was associated with worse survival.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Surrounding tissue invasion and absolute\/relative enhancement ratio were identified as independent predictors for MVI.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>This web-based app predicts MVI and provides real-time data-driven estimates of predictive value.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13244-025-02091-6","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:55:29Z","timestamp":1758808529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative prediction of microvascular invasion in pancreatic neuroendocrine tumors through analysis of portal venous phase CT images"],"prefix":"10.1186","volume":"16","author":[{"given":"Hai-Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ri-Sheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-2808","authenticated-orcid":false,"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"2091_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D et al (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3:1335\u20131342","journal-title":"JAMA Oncol"},{"key":"2091_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.6004\/jnccn.2021.0032","volume":"19","author":"MH Shah","year":"2021","unstructured":"Shah MH, Goldner WS, Benson AB et al (2021) Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19:839\u2013868","journal-title":"J Natl Compr Canc Netw"},{"key":"2091_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2011-300831","volume":"61","author":"JK Ramage","year":"2012","unstructured":"Ramage JK, Ahmed A, Ardill J et al (2012) Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 61:6\u201332","journal-title":"Gut"},{"key":"2091_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000457956","volume":"105","author":"A Perren","year":"2017","unstructured":"Perren A, Couvelard A, Scoazec JY et al (2017) ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology: diagnosis and prognostic stratification. Neuroendocrinology 105:196\u2013200","journal-title":"Neuroendocrinology"},{"key":"2091_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.5114\/pjp.2015.53015","volume":"66","author":"Z Simtniece","year":"2015","unstructured":"Simtniece Z, Vanags A, Strumfa I et al (2015) Morphological and immunohistochemical profile of pancreatic neuroendocrine neoplasms. Pol J Pathol 66:176\u2013194","journal-title":"Pol J Pathol"},{"key":"2091_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S et al (2022) Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol 33:115\u2013154","journal-title":"Endocr Pathol"},{"key":"2091_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00535-021-01827-7","volume":"56","author":"T Ito","year":"2021","unstructured":"Ito T, Masui T, Komoto I et al (2021) JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol 56:1033\u20131044","journal-title":"J Gastroenterol"},{"key":"2091_CR8","doi-asserted-by":"crossref","unstructured":"Mori M, Palumbo D, Muffatti F et al (2023) Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features. Eur Radiol 33:4412\u20134421","DOI":"10.1007\/s00330-022-09351-9"},{"key":"2091_CR9","doi-asserted-by":"crossref","unstructured":"Zhang WH, Xu JF, Hu YH et al (2023) The surgical and therapeutic activities of non-functional pancreatic neuroendocrine tumors at a high-volume institution. Cancers (Basel) 15:1955","DOI":"10.3390\/cancers15071955"},{"key":"2091_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.21873\/cdp.10089","volume":"2","author":"W Izumo","year":"2022","unstructured":"Izumo W, Higuchi R, Furukawa T et al (2022) Evaluation of the significance of lymphatic, microvascular and perineural invasion in patients with pancreatic neuroendocrine neoplasms. Cancer Diagn Progn 2:150\u2013159","journal-title":"Cancer Diagn Progn"},{"key":"2091_CR11","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1245\/s10434-023-13193-0","volume":"30","author":"Y Nanno","year":"2023","unstructured":"Nanno Y, Toyama H, Matsumoto I et al (2023) Reappraisal of malignant risk assessment for small (\u226420 mm) non-functioning pancreatic neuroendocrine tumors. Ann Surg Oncol 30:3493\u20133500","journal-title":"Ann Surg Oncol"},{"key":"2091_CR12","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00330-014-3532-z","volume":"25","author":"DW Kim","year":"2015","unstructured":"Kim DW, Kim HJ, Kim KW et al (2015) Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1\/2 neuroendocrine tumour. Eur Radiol 25:1375\u20131383","journal-title":"Eur Radiol"},{"key":"2091_CR13","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1007\/s00330-022-08891-4","volume":"32","author":"HY Chen","year":"2022","unstructured":"Chen HY, Pan Y, Chen JY et al (2022) Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas. Eur Radiol 32:8317\u20138325","journal-title":"Eur Radiol"},{"key":"2091_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2214\/AJR.19.21921","volume":"215","author":"HY Chen","year":"2020","unstructured":"Chen HY, Zhang XY, Deng XY et al (2020) Grade 3 pancreatic neuroendocrine tumors on MDCT: establishing a diagnostic model and comparing survival against pancreatic ductal adenocarcinoma. AJR Am J Roentgenol 215:390\u2013397","journal-title":"AJR Am J Roentgenol"},{"key":"2091_CR15","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00330-014-3485-2","volume":"25","author":"C Cappelli","year":"2015","unstructured":"Cappelli C, Boggi U, Mazzeo S et al (2015) Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours. Eur Radiol 25:751\u2013759","journal-title":"Eur Radiol"},{"key":"2091_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.108847","volume":"124","author":"B Yang","year":"2020","unstructured":"Yang B, Chen HY, Zhang XY, Pan Y, Lu YF, Yu RS (2020) The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors. Eur J Radiol 124:108847","journal-title":"Eur J Radiol"},{"key":"2091_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.surg.2022.04.013","volume":"172","author":"J Perinel","year":"2022","unstructured":"Perinel J, Nappo G, Zerbi A et al (2022) Sporadic nonfunctional pancreatic neuroendocrine tumors: risk of lymph node metastases and aggressiveness according to tumor size: a multicenter international study. Surgery 172:975\u2013981","journal-title":"Surgery"},{"key":"2091_CR18","doi-asserted-by":"crossref","unstructured":"Partelli S, Muffatti F, Rancoita PMV et al (2019) The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age. Dig Liver Dis 51:735\u2013740","DOI":"10.1016\/j.dld.2019.01.008"},{"key":"2091_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13718-4","volume":"22","author":"J Smith","year":"2022","unstructured":"Smith J, Sun Y, Hijano DR et al (2022) covidscreen: a web app and R Package for assessing asymptomatic COVID-19 testing strategies. BMC Public Health 22:1361","journal-title":"BMC Public Health"},{"key":"2091_CR20","doi-asserted-by":"publisher","first-page":"850279","DOI":"10.3389\/fcimb.2022.850279","volume":"12","author":"Z Ling","year":"2022","unstructured":"Ling Z, Huang S, Wen Z et al (2022) mtTB: a web-based R\/Shiny app for pulmonary tuberculosis screening. Front Cell Infect Microbiol 12:850279","journal-title":"Front Cell Infect Microbiol"},{"key":"2091_CR21","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1007\/s00330-020-06867-w","volume":"30","author":"HJ Park","year":"2020","unstructured":"Park HJ, Kim HJ, Kim KW et al (2020) Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT. Eur Radiol 30:4772\u20134782","journal-title":"Eur Radiol"},{"key":"2091_CR22","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s00330-022-09235-y","volume":"33","author":"HJ Park","year":"2023","unstructured":"Park HJ, Kim HJ, Kim JH et al (2023) Prognostic value of tumor-to-parenchymal contrast enhancement ratio on portal venous-phase CT in pancreatic neuroendocrine neoplasms. Eur Radiol 33:2713\u20132724","journal-title":"Eur Radiol"},{"key":"2091_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.gastro.2013.11.004","volume":"146","author":"MM Al-Hawary","year":"2014","unstructured":"Al-Hawary MM, Francis IR, Chari ST et al (2014) Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Gastroenterology 146:291\u2013304.e291","journal-title":"Gastroenterology"},{"key":"2091_CR24","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1007\/s00330-015-3943-5","volume":"26","author":"DW Kim","year":"2016","unstructured":"Kim DW, Kim HJ, Kim KW et al (2016) Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients. Eur Radiol 26:1320\u20131329","journal-title":"Eur Radiol"},{"key":"2091_CR25","first-page":"471","volume":"68","author":"M Cives","year":"2018","unstructured":"Cives M, Strosberg JR (2018) Gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 68:471\u2013487","journal-title":"CA Cancer J Clin"},{"key":"2091_CR26","doi-asserted-by":"publisher","first-page":"e13343","DOI":"10.1111\/jne.13343","volume":"35","author":"B Kos-Kud\u0142a","year":"2023","unstructured":"Kos-Kud\u0142a B, Casta\u00f1o JP, Denecke T et al (2023) European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J Neuroendocrinol 35:e13343","journal-title":"J Neuroendocrinol"},{"key":"2091_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1148\/radiol.2021210231","volume":"301","author":"Y Nagayama","year":"2021","unstructured":"Nagayama Y, Inoue T, Kato Y et al (2021) Relative enhancement ratio of portal venous phase to unenhanced CT in the diagnosis of lipid-poor adrenal adenomas. Radiology 301:360\u2013368","journal-title":"Radiology"},{"key":"2091_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.745001","volume":"11","author":"HY Chen","year":"2021","unstructured":"Chen HY, Deng XY, Pan Y et al (2021) Pancreatic serous cystic neoplasms and mucinous cystic neoplasms: differential diagnosis by combining imaging features and enhanced CT texture analysis. Front Oncol 11:745001","journal-title":"Front Oncol"},{"key":"2091_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa A, Chang DK, Nones K et al (2017) Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 543:65\u201371","journal-title":"Nature"},{"key":"2091_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000471879","volume":"105","author":"A Sundin","year":"2017","unstructured":"Sundin A, Arnold R, Baudin E et al (2017) ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging. Neuroendocrinology 105:212\u2013244","journal-title":"Neuroendocrinology"},{"key":"2091_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1148\/radiol.2501080291","volume":"250","author":"G d\u2019Assignies","year":"2009","unstructured":"d\u2019Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407\u2013416","journal-title":"Radiology"},{"key":"2091_CR32","doi-asserted-by":"crossref","unstructured":"Addeo P, d\u2019Alessandro A, Averous G et al (2019) Macrovascular venous invasion of pancreatic neuroendocrine tumours: impact on surgical outcomes and survival. HPB (Oxford) 21:653\u2013661","DOI":"10.1016\/j.hpb.2018.10.010"},{"key":"2091_CR33","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/bioinformatics\/bty855","volume":"35","author":"MA Badgeley","year":"2019","unstructured":"Badgeley MA, Liu M, Glicksberg BS et al (2019) CANDI: an R package and Shiny app for annotating radiographs and evaluating computer-aided diagnosis. Bioinformatics 35:1610\u20131612","journal-title":"Bioinformatics"},{"key":"2091_CR34","doi-asserted-by":"publisher","first-page":"e2200137","DOI":"10.1200\/CCI.22.00137","volume":"7","author":"P O\u2019Regan","year":"2023","unstructured":"O\u2019Regan P, Hoskins R, Grave C et al (2023) Digital ECMT Cancer Trial Matching Tool: an open source research application to support oncologists in the identification of precision medicine clinical trials. JCO Clin Cancer Inform 7:e2200137","journal-title":"JCO Clin Cancer Inform"},{"key":"2091_CR35","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/hep4.1921","volume":"6","author":"J Lim","year":"2022","unstructured":"Lim J, Han S, Lee D et al (2022) Identification of hepatic steatosis in living liver donors by machine learning models. Hepatol Commun 6:1689\u20131698","journal-title":"Hepatol Commun"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02091-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-025-02091-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02091-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:55:32Z","timestamp":1758808532000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-025-02091-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2091"],"URL":"https:\/\/doi.org\/10.1186\/s13244-025-02091-6","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the principles outlined in the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (Approval number: 2021-0554) and Zhejiang Cancer Hospital (Approval number: IRB-2024-1321).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All individual details, images and tables are consented to be published. The necessity for obtaining informed consent has been waived by the Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}